Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid
A prospective randomized study has been conducted in Rwanda to compare the efficacy of enoxacin versus nalidixic acid for the treatment of bacillary dysentery in adults. Seventeen patients received nalidixic acid and 21 received enoxacin. All isolates (37 shigella, 1 campylobacter) were sensitive in...
Gespeichert in:
| Veröffentlicht in: | Journal of antimicrobial chemotherapy 1987-05, Vol.19 (5), p.695-698 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 698 |
|---|---|
| container_issue | 5 |
| container_start_page | 695 |
| container_title | Journal of antimicrobial chemotherapy |
| container_volume | 19 |
| creator | De Mol, Patrick Mets, Tony Lagasse, Raphaël Vandepitte, Joseph Mutwewingabo, Anthère Butzler, Jean-Paul |
| description | A prospective randomized study has been conducted in Rwanda to compare the efficacy of enoxacin versus nalidixic acid for the treatment of bacillary dysentery in adults. Seventeen patients received nalidixic acid and 21 received enoxacin. All isolates (37 shigella, 1 campylobacter) were sensitive in vitro to the two drugs. All patients showed a favourable clinical and bacteriological response and the results obtained with both drugs were comparable. Enoxacin seems to be a good alternative to nalidixic acid for bacillary dysentery due to multiresistant shigella. |
| doi_str_mv | 10.1093/jac/19.5.695 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77612701</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>14834411</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-9f6c068f632fd398bc181ef4d172d9756f8b52f76d6c1dab8e626d89676f0e873</originalsourceid><addsrcrecordid>eNqFkEuLFDEUhYMoYzu6cytkIa6snqSS3CTuZHyMMCAMLYibkMoDMlal2qQau_-9abrprasL53wcLh9CrylZU6LZzaN1N1SvxRq0eIJWlAPpeqLpU7QijIhOcsGeoxe1PhJCQIC6QleMESoVW6GHTQl2mUJe8BzxYF0aR1sO2B9qy0I5fMAWu3na2pLqnPEQlr8hZBzyvG9wxjZ7nO2YfNonh1vkX6Jn0Y41vDrfa_Tjy-fN7V13__3rt9uP953jgiydjuAIqAisj55pNTiqaIjcU9l7LQVENYg-SvDgqLeDCtCDVxokRBKUZNfo3Wl3W-Y_u1AXM6XqQvs_h3lXjZRAe0nof0HKFeOcHsH3J9CVudYSotmWNDUdhhJzdG2aa0O1Eaa5bvib8-5umIK_wGe5rX977m11dozFZpfqBVM9FRKOM90JS3UJ-0tty28Dkklh7n7-MvwT4w-92hjO_gERq5W0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>14834411</pqid></control><display><type>article</type><title>Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid</title><source>MEDLINE</source><source>Oxford University Press Journals Digital Archive Legacy</source><creator>De Mol, Patrick ; Mets, Tony ; Lagasse, Raphaël ; Vandepitte, Joseph ; Mutwewingabo, Anthère ; Butzler, Jean-Paul</creator><creatorcontrib>De Mol, Patrick ; Mets, Tony ; Lagasse, Raphaël ; Vandepitte, Joseph ; Mutwewingabo, Anthère ; Butzler, Jean-Paul</creatorcontrib><description>A prospective randomized study has been conducted in Rwanda to compare the efficacy of enoxacin versus nalidixic acid for the treatment of bacillary dysentery in adults. Seventeen patients received nalidixic acid and 21 received enoxacin. All isolates (37 shigella, 1 campylobacter) were sensitive in vitro to the two drugs. All patients showed a favourable clinical and bacteriological response and the results obtained with both drugs were comparable. Enoxacin seems to be a good alternative to nalidixic acid for bacillary dysentery due to multiresistant shigella.</description><identifier>ISSN: 0305-7453</identifier><identifier>EISSN: 1460-2091</identifier><identifier>DOI: 10.1093/jac/19.5.695</identifier><identifier>PMID: 3301783</identifier><identifier>CODEN: JACHDX</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adult ; Anti-Bacterial Agents - therapeutic use ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Biological and medical sciences ; Campylobacter ; Clinical Trials as Topic ; Drug Resistance, Microbial ; Dysentery, Bacillary - drug therapy ; Enoxacin ; Humans ; Medical sciences ; Middle Aged ; Nalidixic Acid - therapeutic use ; Naphthyridines - therapeutic use ; Pharmacology. Drug treatments ; Prospective Studies ; Random Allocation ; Shigella ; Shigella dysenteriae - drug effects ; Shigella flexneri - drug effects</subject><ispartof>Journal of antimicrobial chemotherapy, 1987-05, Vol.19 (5), p.695-698</ispartof><rights>1987 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-9f6c068f632fd398bc181ef4d172d9756f8b52f76d6c1dab8e626d89676f0e873</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=8215765$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3301783$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>De Mol, Patrick</creatorcontrib><creatorcontrib>Mets, Tony</creatorcontrib><creatorcontrib>Lagasse, Raphaël</creatorcontrib><creatorcontrib>Vandepitte, Joseph</creatorcontrib><creatorcontrib>Mutwewingabo, Anthère</creatorcontrib><creatorcontrib>Butzler, Jean-Paul</creatorcontrib><title>Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid</title><title>Journal of antimicrobial chemotherapy</title><addtitle>J Antimicrob Chemother</addtitle><description>A prospective randomized study has been conducted in Rwanda to compare the efficacy of enoxacin versus nalidixic acid for the treatment of bacillary dysentery in adults. Seventeen patients received nalidixic acid and 21 received enoxacin. All isolates (37 shigella, 1 campylobacter) were sensitive in vitro to the two drugs. All patients showed a favourable clinical and bacteriological response and the results obtained with both drugs were comparable. Enoxacin seems to be a good alternative to nalidixic acid for bacillary dysentery due to multiresistant shigella.</description><subject>Adult</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Campylobacter</subject><subject>Clinical Trials as Topic</subject><subject>Drug Resistance, Microbial</subject><subject>Dysentery, Bacillary - drug therapy</subject><subject>Enoxacin</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nalidixic Acid - therapeutic use</subject><subject>Naphthyridines - therapeutic use</subject><subject>Pharmacology. Drug treatments</subject><subject>Prospective Studies</subject><subject>Random Allocation</subject><subject>Shigella</subject><subject>Shigella dysenteriae - drug effects</subject><subject>Shigella flexneri - drug effects</subject><issn>0305-7453</issn><issn>1460-2091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEuLFDEUhYMoYzu6cytkIa6snqSS3CTuZHyMMCAMLYibkMoDMlal2qQau_-9abrprasL53wcLh9CrylZU6LZzaN1N1SvxRq0eIJWlAPpeqLpU7QijIhOcsGeoxe1PhJCQIC6QleMESoVW6GHTQl2mUJe8BzxYF0aR1sO2B9qy0I5fMAWu3na2pLqnPEQlr8hZBzyvG9wxjZ7nO2YfNonh1vkX6Jn0Y41vDrfa_Tjy-fN7V13__3rt9uP953jgiydjuAIqAisj55pNTiqaIjcU9l7LQVENYg-SvDgqLeDCtCDVxokRBKUZNfo3Wl3W-Y_u1AXM6XqQvs_h3lXjZRAe0nof0HKFeOcHsH3J9CVudYSotmWNDUdhhJzdG2aa0O1Eaa5bvib8-5umIK_wGe5rX977m11dozFZpfqBVM9FRKOM90JS3UJ-0tty28Dkklh7n7-MvwT4w-92hjO_gERq5W0</recordid><startdate>19870501</startdate><enddate>19870501</enddate><creator>De Mol, Patrick</creator><creator>Mets, Tony</creator><creator>Lagasse, Raphaël</creator><creator>Vandepitte, Joseph</creator><creator>Mutwewingabo, Anthère</creator><creator>Butzler, Jean-Paul</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>19870501</creationdate><title>Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid</title><author>De Mol, Patrick ; Mets, Tony ; Lagasse, Raphaël ; Vandepitte, Joseph ; Mutwewingabo, Anthère ; Butzler, Jean-Paul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-9f6c068f632fd398bc181ef4d172d9756f8b52f76d6c1dab8e626d89676f0e873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Adult</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Campylobacter</topic><topic>Clinical Trials as Topic</topic><topic>Drug Resistance, Microbial</topic><topic>Dysentery, Bacillary - drug therapy</topic><topic>Enoxacin</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nalidixic Acid - therapeutic use</topic><topic>Naphthyridines - therapeutic use</topic><topic>Pharmacology. Drug treatments</topic><topic>Prospective Studies</topic><topic>Random Allocation</topic><topic>Shigella</topic><topic>Shigella dysenteriae - drug effects</topic><topic>Shigella flexneri - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>De Mol, Patrick</creatorcontrib><creatorcontrib>Mets, Tony</creatorcontrib><creatorcontrib>Lagasse, Raphaël</creatorcontrib><creatorcontrib>Vandepitte, Joseph</creatorcontrib><creatorcontrib>Mutwewingabo, Anthère</creatorcontrib><creatorcontrib>Butzler, Jean-Paul</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of antimicrobial chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>De Mol, Patrick</au><au>Mets, Tony</au><au>Lagasse, Raphaël</au><au>Vandepitte, Joseph</au><au>Mutwewingabo, Anthère</au><au>Butzler, Jean-Paul</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid</atitle><jtitle>Journal of antimicrobial chemotherapy</jtitle><addtitle>J Antimicrob Chemother</addtitle><date>1987-05-01</date><risdate>1987</risdate><volume>19</volume><issue>5</issue><spage>695</spage><epage>698</epage><pages>695-698</pages><issn>0305-7453</issn><eissn>1460-2091</eissn><coden>JACHDX</coden><abstract>A prospective randomized study has been conducted in Rwanda to compare the efficacy of enoxacin versus nalidixic acid for the treatment of bacillary dysentery in adults. Seventeen patients received nalidixic acid and 21 received enoxacin. All isolates (37 shigella, 1 campylobacter) were sensitive in vitro to the two drugs. All patients showed a favourable clinical and bacteriological response and the results obtained with both drugs were comparable. Enoxacin seems to be a good alternative to nalidixic acid for bacillary dysentery due to multiresistant shigella.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>3301783</pmid><doi>10.1093/jac/19.5.695</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0305-7453 |
| ispartof | Journal of antimicrobial chemotherapy, 1987-05, Vol.19 (5), p.695-698 |
| issn | 0305-7453 1460-2091 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_77612701 |
| source | MEDLINE; Oxford University Press Journals Digital Archive Legacy |
| subjects | Adult Anti-Bacterial Agents - therapeutic use Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Campylobacter Clinical Trials as Topic Drug Resistance, Microbial Dysentery, Bacillary - drug therapy Enoxacin Humans Medical sciences Middle Aged Nalidixic Acid - therapeutic use Naphthyridines - therapeutic use Pharmacology. Drug treatments Prospective Studies Random Allocation Shigella Shigella dysenteriae - drug effects Shigella flexneri - drug effects |
| title | Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T06%3A21%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20bacillary%20dysentery:%20a%20comparison%20between%20enoxacin%20and%20nalidixic%20acid&rft.jtitle=Journal%20of%20antimicrobial%20chemotherapy&rft.au=De%20Mol,%20Patrick&rft.date=1987-05-01&rft.volume=19&rft.issue=5&rft.spage=695&rft.epage=698&rft.pages=695-698&rft.issn=0305-7453&rft.eissn=1460-2091&rft.coden=JACHDX&rft_id=info:doi/10.1093/jac/19.5.695&rft_dat=%3Cproquest_cross%3E14834411%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=14834411&rft_id=info:pmid/3301783&rfr_iscdi=true |